Wilmington, DE, United States of America

Guo-Hua Chu

This inventor holds 12 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Adolor Corporation, Venatorx Pharmaceuticals, Inc.. Active years: 2006-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guo-Hua Chu. Retrieved from https://idiyas.com/inventor/guo-hua-chu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 6)

% Patents Active = 50.0

EPO Patents = 1 (Patent Applications = 8)

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 19(Granted Patents)

Location History:

Wilmington, DE (US) (2006 - 2011)
Exton, PA (US) (2009 - 2024)

Company Filing History:

Venatorx Pharmaceuticals, Inc.

patents

Years Active: 2006-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12173018 - Penicillin-binding protein inhibitors (2024-12-24),

2. 12102648 - Orally-bioavailable nucleoside analogs (2024-10-01),

3. 12084445 - Broad-spectrum carbapenems (2024-09-10),

4. 11638715 - Orally-bioavailable nucleoside analogs (2023-05-02),

5. 11332485 - Penicillin-binding protein inhibitors (2022-05-17),

6. 11267826 - Penicillin-binding protein inhibitors (2022-03-08),

7. 8022060 - Spirocyclic heterocyclic derivatives and methods of their use (2011-09-20),

8. 7906646 - Spirocyclic heterocyclic derivatives and methods of their use (2011-03-15),

9. 7598261 - Spirocyclic heterocyclic derivatives and methods of their use (2009-10-06),

10. 7576207 - Spirocyclic heterocyclic derivatives and methods of their use (2009-08-18),

11. 7160902 - Amide derivatives and methods of their use (2007-01-09),

12. 7034051 - Fused bicyclic carboxamide derivatives and methods of their use (2006-04-25),

Title: Guo-Hua Chu: Innovator in Antibacterial and Antiviral Research

Introduction

Guo-Hua Chu is a prominent inventor based in Wilmington, DE, known for his significant contributions to the fields of antibacterial and antiviral research. With a total of 12 patents to his name, he has made remarkable strides in developing innovative compounds that address critical health challenges.

Latest Patents

Among his latest patents, Guo-Hua Chu has developed penicillin-binding protein inhibitors. These compounds are designed to modulate the transpeptidase function of bacterial penicillin-binding proteins, serving as effective antibacterial agents. In certain embodiments, these compounds inhibit penicillin-binding proteins, making them useful in treating bacterial infections. Additionally, he has created orally-bioavailable nucleoside analogs, which are pharmaceutical compositions aimed at treating coronavirus infections, including SARS-CoV-2.

Career Highlights

Throughout his career, Guo-Hua Chu has worked with notable companies such as Venatorx Pharmaceuticals, Inc. and Adolor Corporation. His work in these organizations has been instrumental in advancing research and development in the pharmaceutical industry.

Collaborations

Guo-Hua Chu has collaborated with esteemed colleagues, including Christopher J. Burns and Steven Armen Boyd, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Guo-Hua Chu's innovative work in developing antibacterial and antiviral agents highlights his significant impact on medical research. His contributions continue to pave the way for advancements in treating infectious diseases.

Profile summary based on public USPTO records.